Skip to main content

Market Overview

Sanofi Offers Cash Buyout For Kiadis

  • Sanofi SA (NASDAQ: SNY) has launched a takeover offer for Kiadis Pharma NV (OTC: KIADF) to represent an aggregate adjusted equity value of €308 million. The takeover offer is priced at €5.45 per share in cash.
  • Kiadis’ board said it supported the offer, as it felt Sanofi’s infrastructure and capabilities would help develop Kiadis’ pipeline of products.
  • Kiadis’ proprietary platform is based on allogeneic or ‘off-the-shelf’ NK cells from a healthy donor that seeks and identifies malignant cancer cells and has broad application across various tumor types.
  • The transaction was announced in November last year.
  • Price Action: SNY stock is down 0.8% at $47.31 in premarket on the last check Friday.

Related Articles (SNY + KIADF)

View Comments and Join the Discussion!

Posted-In: Biotech M&A News Health Care General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at